Project Grant HT94252410165
Award Date 9/1/24
Completion Date 2/2/26
Dollars Obligated $188K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Switzerland
Similar Awards
- This federal Project Grant award of $219,568.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research by Universitat Bern to investigate the role of intestinal secreted microRNAs in regulating the gut microflora and their impact on inflammatory bowel disease. The research aims to improve understanding of the underlying mechanisms of this condition, which is of relevance to military health. The award has a performance...
- The U.S. Defense Health Agency awarded a $989,167 Project Grant to the University of Bern in Switzerland under the Military Medical Research and Development program (CFDA 12.420). The grant, effective from February 15, 2024 to February 14, 2027, supports research to define the role of the SWI/SNF chromatin remodeling complex in advanced metastatic castration-resistant prostate cancer (mCRPC) therapy resistance. Through this grant, the University of Bern will conduct basic, translational, and...
- The Department of the Army Medical Command awarded a $438,916 project grant to Universitat Bern in Switzerland under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 1, 2022 to August 31, 2026 to target PARP inhibitor resistance. Through this funding, Universitat Bern researchers will investigate medical solutions for targeting resistance to poly (ADP-ribose) polymerase inhibitors, an area of focus under the Military Medical...
- This federal Project Grant award, valued at $548,133.00 and awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research at the University of Basel in Switzerland focused on "Neuronal Regulation of Antitumor Immunity". The award, which began on September 15, 2024 and is scheduled for completion by September 14, 2027, aims to conduct advanced biomedical research investigating the role of neuronal processes in...
- The Defense Health Agency awarded a $1,184,252 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Centre Hospitalier Universitaire Vaudois (Chuv), a non-profit hospital and research institution in Lausanne, Switzerland. The grant will fund the development of a clinical-grade spinal cord neuroprosthesis to alleviate locomotor deficits in people with Parkinson's disease. The project period is from Sep 1, 2025 to Aug 31, 2028. Chuv has established...
- This Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $406,776.00 to Baylor University to develop a novel graft-localized drug delivery platform for reducing innate inflammation and optimizing immunosuppression in vascularized composite allotransplantation. The 2-year project, spanning September 2024 to September 2026, aims to advance innovative biomedical research solutions to improve health outcomes for...
- This Project Grant from the Department of the Army Medical Command will provide $797,100 to the Centre Hospitalier Universitaire Vaudois (CHUV) in Switzerland from August 1, 2022 through July 31, 2026 to support understanding T-cell senescence to optimize ovarian cancer immunotherapy. The grant falls under the Military Medical Research and Development program (CFDA 12.420), which aims to transform healthcare for service members and the public through innovative biomedical research...
- The U.S. Defense Health Agency awarded a $199,966 Project Grant to the Ecole Polytechnique Federale De Lausanne (EPFL) in Switzerland under the Military Medical Research and Development program (CFDA 12.420). The grant supports advanced biomedical research to develop neuroprosthetic technologies for managing hypotensive complications in Parkinson's disease. The project has a performance period from August 1, 2025 to July 31, 2027. EPFL has demonstrated expertise in delivering complex...
- The Defense Health Agency awarded a $410,000 Project Grant titled "Localized and Inflammation-Responsive Immunotherapy of VCA Rejection" to The Geneva Foundation, a 501(c)3 non-profit organization that supports medical research and education for the U.S. military. This grant is part of the "Military Medical Research and Development" program (CFDA 12.420), which funds basic, applied, and advanced biomedical research to transform healthcare for Service Members and the public...
- The Department of the Army Medical Command awarded Ospedale San Raffaele S.R.L. a $650,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will support research from September 30, 2022 to September 29, 2025 to engineer thymic selection to control the development of alloreactive T cells and promote vascularized composite allograft acceptance. The Military Medical Research and Development program aims to transform military and public health care...